Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages

Jana J von Lindern1, Daniel Rojo, Kathie Grovit-Ferbas

  • 1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555, USA.

Journal of Virology
|March 1, 2003
PubMed

Insights

Monoclonal antibody targeting CD63 inhibits human immunodeficiency virus type 1 (HIV-1) infection in macrophages. This inhibition occurs post-fusion but before reverse transcription, suggesting a specific role for CD63 in macrophage tropism.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Macrophages and CD4(+) lymphocytes are primary targets for HIV-1.
  • Molecular mechanisms of HIV-1 infection can differ between cell types.
  • Identifying cellular molecules involved in macrophage infection is crucial.

Purpose of the Study:

  • To identify cellular molecules involved in HIV-1 infection of macrophages.
  • To investigate the role of CD63 in HIV-1 macrophage tropism.
  • To determine the stage of viral replication affected by CD63.

Main Methods:

  • Utilized monoclonal antibodies (MAbs) against tetraspanins, including CD63.
  • Assessed HIV-1 infection inhibition in primary macrophages.
  • Performed cell-cell fusion assays and quantitative PCR for viral DNA.
  • Analyzed changes in CD4, CCR5, and beta-chemokine levels.

Main Results:

  • Anti-CD63 MAb inhibited infection by R5 and dualtropic HIV-1 strains in macrophages.
  • Inhibition was post-fusion but prior to reverse transcription.
  • Other tetraspanin MAbs (anti-CD9, -CD81, -CD82) did not inhibit infection.
  • Anti-CD63 did not affect infection of lymphocytes or other cell lines.

Conclusions:

  • CD63 plays a specific role in HIV-1 infection of macrophages.
  • The inhibitory mechanism involves a post-fusion, pre-reverse transcription step.
  • CD63's role in HIV-1 infection appears to be macrophage-specific.